Literature DB >> 33475334

Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Pei Teng Lum1, Mahendran Sekar1, Siew Hua Gan2, Srinivasa Reddy Bonam3, Mohd Farooq Shaikh4.   

Abstract

Huntington's disease (HD), a neurodegenerative disease, normally starts in the prime of adult life, followed by a gradual occurrence of characteristic psychiatric disturbances and cognitive and motor dysfunction. To the best of our knowledge, there is no treatment available to completely mitigate the progression of HD. Among various therapeutic approaches, exhaustive literature reports have confirmed the medicinal benefits of natural products in HD experimental models. Building on this information, this review presents a brief overview of the neuroprotective mechanism(s) of natural products against in vitro/in vivo models of HD. Relevant studies were identified from several scientific databases, including PubMed, ScienceDirect, Scopus, and Google Scholar. After screening through literature from 2005 to the present, a total of 14 medicinal plant species and 30 naturally isolated compounds investigated against HD based on either in vitro or in vivo models were included in the present review. Behavioral outcomes in the HD in vivo model showed that natural compounds significantly attenuated 3-nitropropionic acid (3-NP) induced memory loss and motor incoordination. The biochemical alteration has been markedly alleviated with reduced lipid peroxidation, increased endogenous enzymatic antioxidants, reduced acetylcholinesterase activity, and increased mitochondrial energy production. Interestingly, following treatment with certain natural products, 3-NP-induced damage in the striatum was ameliorated, as seen histologically. Overall, natural products afforded varying degrees of neuroprotection in preclinical studies of HD via antioxidant and anti-inflammatory properties, preservation of mitochondrial function, inhibition of apoptosis, and induction of autophagy.

Entities:  

Keywords:  3-nitropropionic acid; Huntington’s disease; herbal medicine; natural products; neurodegenerative; neuroprotective

Mesh:

Substances:

Year:  2021        PMID: 33475334     DOI: 10.1021/acschemneuro.0c00824

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  6 in total

Review 1.  Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Authors:  Nurul Amirah Mohd Zaid; Mahendran Sekar; Srinivasa Reddy Bonam; Siew Hua Gan; Pei Teng Lum; M Yasmin Begum; Nur Najihah Izzati Mat Rani; Jaishree Vaijanathappa; Yuan Seng Wu; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Drug Des Devel Ther       Date:  2022-01-06       Impact factor: 4.162

2.  Novel Substituted Heteroaryl Compounds for Treating Huntington's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-11-15       Impact factor: 4.345

3.  Novel Substituted Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-07-20       Impact factor: 4.632

Review 4.  A Double-Pronged Sword: XJB-5-131 Is a Suppressor of Somatic Instability and Toxicity in Huntington's Disease.

Authors:  Pater Wipf; Aris A Polyzos; Cynthia T McMurray
Journal:  J Huntingtons Dis       Date:  2022

5.  Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.

Authors:  Muhammad Afzal; Nadeem Sayyed; Khalid Saad Alharbi; Sami I Alzarea; Mohammed Salem Alshammari; Fadhel A Alomar; Sattam Khulaif Alenezi; Anwarulabedin Mohsin Quazi; Abdulaziz I Alzarea; Imran Kazmi
Journal:  Biomolecules       Date:  2022-07-23

6.  Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.

Authors:  Priya Sharma; Manish Kumar; Nitin Bansal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-01       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.